[{"start_date": "2025-07-01", "end_date": "2025-09-30", "filing_date": "2025-11-13", "acceptance_datetime": "2025-11-13T13:00:52Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2025", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-25-034617", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-25-034617/files/mnpr20250930_10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -3503480.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -3503480.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -65879, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss": {"value": -3503480.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "balance_sheet": {"noncurrent_assets": {"value": 106666, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 141557848.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "assets": {"value": 144197278.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 144090612.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 2639430.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 2568549.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 141557848.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 144197278.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 70881, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow": {"value": 88175050.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -2090532.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": 92391609.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -2090532.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": 88175050.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -2126027.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 92391609.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -2126027.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "income_statement": {"operating_income_loss": {"value": -4093074.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -3437601.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 7123849.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 1503325.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_available_to_common_stockholders_basic": {"value": -3437601.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.48, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss": {"value": -3437601.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -3437601.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -3437601.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 4093074.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 2589749.0, "unit": "USD", "label": "Research and Development", "order": 1030}}}}, {"start_date": "2025-04-01", "end_date": "2025-06-30", "filing_date": "2025-08-12", "acceptance_datetime": "2025-08-12T12:00:56Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2025", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-25-026042", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-25-026042/files/mnpr20250630_10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -2453526.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -2354165.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 99361, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "income_statement": {"research_and_development": {"value": 1730000.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2453526.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "basic_earnings_per_share": {"value": -0.35, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_expenses": {"value": 3234295.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_after_tax": {"value": -2453526.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 1504295.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -2453526.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_income_loss": {"value": -3234295.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -2453526.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_average_shares": {"value": 6998082.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss": {"value": -2453526.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 1663979.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 53747703.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 118170, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 53865873.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 1583613.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 52201894.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 53865873.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 52201894.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "cash_flow_statement": {"net_cash_flow": {"value": -206922, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -1077371.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 1187294.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities": {"value": -316845, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -1077371.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": -316845, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_continuing": {"value": -206922, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": 1187294.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}}}}, {"start_date": "2025-01-01", "end_date": "2025-03-31", "filing_date": "2025-05-13", "acceptance_datetime": "2025-05-13T12:00:57Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2025", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-25-016263", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-25-016263/files/mnpr20250331_10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -325828, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_investing_activities_continuing": {"value": -325828, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -6104826.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -5663316.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -115682, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -115682, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -5663316.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_continuing": {"value": -6104826.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "balance_sheet": {"liabilities": {"value": 1491960.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": -53593358.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 55085318.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 9102, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 53593358.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 55085318.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 53593358.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 55076216.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "income_statement": {"basic_earnings_per_share": {"value": -0.38, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2624972.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -2624972.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_income_loss": {"value": -3221817.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_before_tax": {"value": -2624972.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -2624972.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_expenses": {"value": 3221817.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -2624972.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 1643375.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 6987381.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "other_operating_expenses": {"value": 1578442.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -2624972.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -2623387.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -57776, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}}}, {"start_date": "2024-10-01", "end_date": "2024-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2024", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "financials": {"comprehensive_income": {"comprehensive_income_loss": {"value": -10878625.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -10878625.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 46983, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_parent": {"value": -10878625.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -14338403.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -1998418.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": 42955436.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities": {"value": -1998418.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_continuing": {"value": 42955436.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"net_income_loss": {"value": -10925608.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -11074644.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 9924620.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_expenses": {"value": 11074644.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": -10924808.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 1150024.0, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -10925608.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -10925608.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_earnings_per_share": {"value": -2.75, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -10925608.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "basic_average_shares": {"value": 370881, "unit": "shares", "label": "Basic Average Shares", "order": 4400}}, "balance_sheet": {"assets": {"value": 60291071.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_liabilities": {"value": 5254300.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 55036771.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 60291071.0, "unit": "USD", "label": "Current Assets", "order": 200}, "liabilities": {"value": 5254300.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities_and_equity": {"value": 60291071.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity": {"value": 55036771.0, "unit": "USD", "label": "Equity", "order": 1400}}}}, {"start_date": "2024-07-01", "end_date": "2024-09-30", "filing_date": "2024-11-08", "acceptance_datetime": "2024-11-08T13:01:12Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2024", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-24-034048", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-24-034048/files/mnpr20240930_10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": -1323525.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -19249, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "comprehensive_income_loss_attributable_to_parent": {"value": -1323525.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -1323525.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"current_liabilities": {"value": 1122867.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 1122867.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 6069654.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 4946787.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_parent": {"value": 4946787.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 6069654.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 6069654.0, "unit": "USD", "label": "Assets", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -1073500.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 985730, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -1073500.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -3259732.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": -3259732.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -1304276.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -1304276.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 984278, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 590624, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 3520398.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "revenues": {"value": 0, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 1574902.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -1574902.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss": {"value": -1304276.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss_available_to_common_stockholders_basic": {"value": -1304276.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -1304276.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "basic_earnings_per_share": {"value": -0.37, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}}}, {"start_date": "2024-04-01", "end_date": "2024-06-30", "filing_date": "2024-08-09", "acceptance_datetime": "2024-08-09T12:02:22Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2024", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-24-025651", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-24-025651/files/mnpr20240630_10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -1676798.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -1676798.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -2423, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -9919, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -1689140.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -1689140.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": -9919, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities": {"value": -2423, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "balance_sheet": {"assets": {"value": 7179788.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 6090325.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": -6090325.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity": {"value": 6090325.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities": {"value": 1089462.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 7179788.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 7179788.0, "unit": "USD", "label": "Current Assets", "order": 200}}, "comprehensive_income": {"other_comprehensive_income_loss_attributable_to_parent": {"value": 4027, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -1711282.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -1715309.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"income_loss_from_continuing_operations_before_tax": {"value": -1715309.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 657806, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss": {"value": -1715309.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "income_loss_from_continuing_operations_after_tax": {"value": -1715309.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -1788784.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 1788784.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "interest_income_expense_operating_net": {"value": 73475, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_earnings_per_share": {"value": -0.1, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "net_income_loss_attributable_to_parent": {"value": -1715309.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "revenues": {"value": 73475, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -1715309.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_income_expense_after_provision_for_losses": {"value": 73475, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 1862259.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "basic_average_shares": {"value": 17514637.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "research_and_development": {"value": 1130978.0, "unit": "USD", "label": "Research and Development", "order": 1030}}}}, {"start_date": "2024-01-01", "end_date": "2024-03-31", "filing_date": "2024-05-09", "acceptance_datetime": "2024-05-09T11:00:58Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2024", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-24-015454", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-24-015454/files/mnpr20240331_10q_htm.xml", "financials": {"balance_sheet": {"assets": {"value": 8912296.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 7477135.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 1435160.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 8912296.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 8912296.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 7477135.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": -7477135.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"basic_earnings_per_share": {"value": -0.1, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "operating_income_loss": {"value": -1723391.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_income_expense_after_provision_for_losses": {"value": 82165, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "costs_and_expenses": {"value": 1805556.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "other_operating_expenses": {"value": 757281, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "basic_average_shares": {"value": 15979816.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_attributable_to_parent": {"value": -1641226.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -1641226.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_income_expense_operating_net": {"value": 82165, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "revenues": {"value": 82165, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_expenses": {"value": 1723391.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -1641226.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "income_loss_from_continuing_operations_after_tax": {"value": -1641226.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 966110, "unit": "USD", "label": "Research and Development", "order": 1030}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "income_loss_from_continuing_operations_before_tax": {"value": -1641226.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "cash_flow_statement": {"net_cash_flow": {"value": 543151, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_continuing": {"value": 543151, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -1655423.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 3181881.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_financing_activities_continuing": {"value": 3181881.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -983307, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -983307, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -1655423.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -1622863.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -1641226.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 18363, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}}}, {"start_date": "2023-10-01", "end_date": "2023-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2023", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "financials": {"income_statement": {"basic_average_shares": {"value": 272175, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "research_and_development": {"value": 1035591.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss_attributable_to_parent": {"value": -1813915.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -1813915.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.12, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "other_operating_expenses": {"value": 876397, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_income_loss": {"value": -1911988.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -1813915.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_income_expense_after_provision_for_losses": {"value": 98073, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "costs_and_expenses": {"value": 2010061.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "operating_expenses": {"value": 1911988.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "income_loss_from_continuing_operations_before_tax": {"value": 98073, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "income_loss_from_continuing_operations_after_tax": {"value": -1813915.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_income_expense_operating_net": {"value": 98073, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "revenues": {"value": 98073, "unit": "USD", "label": "Revenues", "order": 100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}}, "balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 5587766.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 7332513.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 1757393.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_parent": {"value": 5587766.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 1757393.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 7345159.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 7345159.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 12646, "unit": "USD", "label": "Noncurrent Assets", "order": 300}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 2970435.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": 334548, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 334548, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 1759084.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": 1759084.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -1545899.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -1545899.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": 2970435.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -18081, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -1831996.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -1831996.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -1831996.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}}}, {"start_date": "2023-07-01", "end_date": "2023-09-30", "filing_date": "2023-11-09", "acceptance_datetime": "2023-11-09T12:01:00Z", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2023", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-23-031066", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-23-031066/files/mnpr20230930_10q_htm.xml", "financials": {"balance_sheet": {"equity": {"value": 6611330.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 1981802.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_parent": {"value": 6611330.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 8568044.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 25088, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "assets": {"value": 8593132.0, "unit": "USD", "label": "Assets", "order": 100}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 1981802.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 8593132.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": -13052, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": -1706162.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -1939813.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": 246703, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 246703, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_operating_activities_continuing": {"value": -1939813.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": -13052, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow": {"value": -1706162.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -3273, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -1957007.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -1957007.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -1957007.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"interest_income_expense_after_provision_for_losses": {"value": 112260, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "revenues": {"value": 112260, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": 112260, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_available_to_common_stockholders_basic": {"value": -1953734.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 2065994.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_income_loss": {"value": -2065994.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "research_and_development": {"value": 1316520.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "other_operating_expenses": {"value": 749474, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "interest_income_expense_operating_net": {"value": 112260, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "costs_and_expenses": {"value": 2178254.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -1953734.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -1953734.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.14, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "basic_average_shares": {"value": 14118397.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "net_income_loss_attributable_to_parent": {"value": -1953734.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}}}, {"start_date": "2023-04-01", "end_date": "2023-06-30", "filing_date": "2023-08-10", "acceptance_datetime": "2023-08-10T11:00:29Z", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2023", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001437749-23-022874", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001437749-23-022874/files/mnpr20230630_10q_htm.xml", "financials": {"income_statement": {"costs_and_expenses": {"value": 2456427.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss": {"value": -2199991.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -2328209.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "income_loss_from_continuing_operations_after_tax": {"value": -2199991.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_before_tax": {"value": -2199991.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "research_and_development": {"value": 1594713.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "interest_income_expense_operating_net": {"value": 128218, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "basic_average_shares": {"value": 13420029.0, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2199991.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 2328209.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 128218, "unit": "USD", "label": "Revenues", "order": 100}, "interest_income_expense_after_provision_for_losses": {"value": 128218, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "other_operating_expenses": {"value": 733496, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -2199991.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "basic_earnings_per_share": {"value": -0.16, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": 641178, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": 2953808.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_continuing": {"value": 1493518.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -2101468.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities_continuing": {"value": 2953808.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -2101468.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 1493518.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 641178, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "comprehensive_income": {"other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -2224556.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -2199991.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -24565, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}}, "balance_sheet": {"noncurrent_assets": {"value": 37330, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 7836783.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities": {"value": 2501821.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 10301274.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities_and_equity": {"value": 10338604.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 10338604.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 2501821.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 7836783.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}}}, {"start_date": "2023-01-01", "end_date": "2023-03-31", "filing_date": "2023-05-11", "acceptance_datetime": "2023-05-11T11:01:17Z", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2023", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001654954-23-006119", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001654954-23-006119/files/mnpr_10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": -2449758.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities_continuing": {"value": -983443, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": -983443, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -2271113.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_operating_activities_continuing": {"value": -2271113.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow": {"value": -2449758.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 804798, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": 804798, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}, "balance_sheet": {"other_current_assets": {"value": 1359606.0, "unit": "USD", "label": "Other Current Assets", "order": 250}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 49376, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "cash": {"value": 10423444.0, "unit": "USD", "label": "Cash", "order": 210}, "equity_attributable_to_parent": {"value": 8944661.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 8944661.0, "unit": "USD", "label": "Equity", "order": 1400}, "liabilities_and_equity": {"value": 11832426.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 11832426.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities": {"value": 2887765.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 11783050.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "current_liabilities": {"value": 2887765.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}, "income_statement": {"income_loss_from_continuing_operations_after_tax": {"value": -2434556.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "operating_income_loss": {"value": -2525044.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "operating_expenses": {"value": 2525044.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss": {"value": -2434556.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "basic_earnings_per_share": {"value": -0.18999999999999997, "unit": "USD / shares", "label": "Basic Earnings Per Share", "order": 4200}, "basic_average_shares": {"value": -156259, "unit": "shares", "label": "Basic Average Shares", "order": 4400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "benefits_costs_expenses": {"value": 2525044.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_income_expense_after_provision_for_losses": {"value": 90488, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "research_and_development": {"value": 1653369.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -2434556.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "interest_income_expense_operating_net": {"value": 90488, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "costs_and_expenses": {"value": 2525044.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2434556.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "revenues": {"value": 90488, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 871675, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "net_income_loss_attributable_to_parent": {"value": -2434556.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -2434556.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": 22845, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": 0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -2434556.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}}}, {"start_date": "2022-10-01", "end_date": "2022-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2022", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -2930381.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": -34043, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -2930381.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -10951128.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -12114197.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -1301806.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": 138737, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities": {"value": -10951128.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow": {"value": -12114197.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": 138737, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_operating_activities": {"value": -1301806.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}, "income_statement": {"operating_expenses": {"value": 2908998.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "research_and_development": {"value": 2102968.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "benefits_costs_expenses": {"value": 2908998.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_income_expense_after_provision_for_losses": {"value": 12660, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "costs_and_expenses": {"value": 2908998.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2896338.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -2896338.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "income_loss_from_continuing_operations_before_tax": {"value": -2896338.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_income_expense_operating_net": {"value": 12660, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "revenues": {"value": 12660, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_parent": {"value": -2896338.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "net_income_loss": {"value": -2896338.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "operating_income_loss": {"value": -2908998.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "other_operating_expenses": {"value": 806030, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "balance_sheet": {"liabilities_and_equity": {"value": 13226954.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "noncurrent_assets": {"value": 61228, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity_attributable_to_parent": {"value": 10089652.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_liabilities": {"value": 3128894.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "cash": {"value": 12182496.0, "unit": "USD", "label": "Cash", "order": 210}, "other_current_assets": {"value": 983230, "unit": "USD", "label": "Other Current Assets", "order": 250}, "noncurrent_liabilities": {"value": 8408, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 3137302.0, "unit": "USD", "label": "Liabilities", "order": 600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity": {"value": 10089652.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_assets": {"value": 13165726.0, "unit": "USD", "label": "Current Assets", "order": 200}, "assets": {"value": 13226954.0, "unit": "USD", "label": "Assets", "order": 100}}}}, {"start_date": "2022-07-01", "end_date": "2022-09-30", "filing_date": "2022-11-10", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2022", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001654954-22-014939", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001654954-22-014939/files/mnpr_10q_htm.xml", "financials": {"income_statement": {"benefits_costs_expenses": {"value": 2407345.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "operating_expenses": {"value": 2407345.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "costs_and_expenses": {"value": 2407345.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "revenues": {"value": 7698, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "income_loss_from_continuing_operations_after_tax": {"value": -2399647.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2399647.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "interest_income_expense_operating_net": {"value": 7698, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "income_loss_from_continuing_operations_before_tax": {"value": -2399647.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "other_operating_expenses": {"value": 675115, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "research_and_development": {"value": 1732230.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "net_income_loss": {"value": -2399647.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_income_loss": {"value": -2407345.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "net_income_loss_attributable_to_parent": {"value": -2399647.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_income_expense_after_provision_for_losses": {"value": 7698, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 2172216.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities_continuing": {"value": -2148478.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 2172216.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -2148478.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": 0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": -23738, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -23738, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": 0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -2374128.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 25519, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -2374128.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "balance_sheet": {"noncurrent_assets": {"value": 72889, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "current_assets": {"value": 14372161.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity": {"value": 12509898.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_liabilities": {"value": 20850, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 14445050.0, "unit": "USD", "label": "Assets", "order": 100}, "equity_attributable_to_parent": {"value": 12509898.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "liabilities": {"value": 1935152.0, "unit": "USD", "label": "Liabilities", "order": 600}, "liabilities_and_equity": {"value": 14445050.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 1914302.0, "unit": "USD", "label": "Current Liabilities", "order": 700}}}}, {"start_date": "2022-04-01", "end_date": "2022-06-30", "filing_date": "2022-08-11", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2022", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001654954-22-011015", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001654954-22-011015/files/mnpr_10q_htm.xml", "financials": {"balance_sheet": {"liabilities_and_equity": {"value": 16737111.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_liabilities": {"value": 2186996.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 2220088.0, "unit": "USD", "label": "Liabilities", "order": 600}, "assets": {"value": 16737111.0, "unit": "USD", "label": "Assets", "order": 100}, "current_assets": {"value": 16652748.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 14517023.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_assets": {"value": 84363, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 14517023.0, "unit": "USD", "label": "Equity", "order": 1400}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2762931.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "operating_expenses": {"value": 2763348.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 417, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": -2762931.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "benefits_costs_expenses": {"value": 2763348.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "research_and_development": {"value": 2078471.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "interest_income_expense_after_provision_for_losses": {"value": 417, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "net_income_loss": {"value": -2762931.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_parent": {"value": -2762931.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "operating_income_loss": {"value": -2763348.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_income_expense_operating_net": {"value": 417, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "costs_and_expenses": {"value": 2763348.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -2762931.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "other_operating_expenses": {"value": 684877, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -2741721.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 21210, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss": {"value": -2762931.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "cash_flow_statement": {"net_cash_flow_continuing": {"value": 2484825.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_financing_activities_continuing": {"value": -65460, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 2484825.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities_continuing": {"value": 3861060.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_investing_activities": {"value": 3861060.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -1310775.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_operating_activities": {"value": -1310775.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities": {"value": -65460, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}}}}, {"start_date": "2022-01-01", "end_date": "2022-03-31", "filing_date": "2022-05-12", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2022", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001654954-22-006507", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001654954-22-006507/files/mnpr_10q_htm.xml", "financials": {"income_statement": {"operating_income_loss": {"value": -2457186.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "costs_and_expenses": {"value": -2456258.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "research_and_development": {"value": 1677932.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "revenues": {"value": 464, "unit": "USD", "label": "Revenues", "order": 100}, "benefits_costs_expenses": {"value": -2456258.0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "income_loss_from_continuing_operations_before_tax": {"value": -2456722.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2456722.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -2456722.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "net_income_loss": {"value": -2456722.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "operating_expenses": {"value": 2457186.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "other_operating_expenses": {"value": 779254, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "interest_income_expense_after_provision_for_losses": {"value": 464, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss_attributable_to_parent": {"value": -2456722.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "interest_income_expense_operating_net": {"value": 464, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}}, "balance_sheet": {"assets": {"value": 18066373.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 16966911.0, "unit": "USD", "label": "Equity", "order": 1400}, "noncurrent_assets": {"value": 53694, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 1099462.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_liabilities": {"value": 1074124.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 18066373.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "current_assets": {"value": 18012679.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "equity_attributable_to_parent": {"value": 16966911.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -584, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -584, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss_attributable_to_parent": {"value": -2457306.0, "unit": "USD", "label": "Other Comprehensive Income/Loss Attributable To Parent", "order": 600}, "other_comprehensive_income_loss": {"value": -584, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_operating_activities": {"value": -2467500.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow": {"value": -2484825.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities_continuing": {"value": -16666, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_investing_activities_continuing": {"value": -659, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities": {"value": -16666, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -2484825.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_investing_activities": {"value": -659, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -2467500.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}}}, {"start_date": "2021-10-01", "end_date": "2021-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2021", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -2678606.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -2678606.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 6424618.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": -18199580.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": 12602897.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -7772, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -7772, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -5604455.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -5604455.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_investing_activities": {"value": -18199580.0, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": 12602897.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}}, "balance_sheet": {"equity": {"value": 18941071.0, "unit": "USD", "label": "Equity", "order": 1400}, "assets": {"value": 20521614.0, "unit": "USD", "label": "Assets", "order": 100}, "current_liabilities": {"value": 1580543.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "current_assets": {"value": 20521614.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 0, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 20521614.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 18941071.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities": {"value": 1580543.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "operating_expenses": {"value": 2681118.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "other_operating_expenses": {"value": 698441, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "operating_income_loss": {"value": -2681118.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "research_and_development": {"value": 1982677.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "interest_income_expense_after_provision_for_losses": {"value": 525, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "costs_and_expenses": {"value": 2681643.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "net_income_loss_attributable_to_parent": {"value": -2680593.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "income_loss_from_continuing_operations_after_tax": {"value": -2680593.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "interest_income_expense_operating_net": {"value": 525, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "revenues": {"value": 525, "unit": "USD", "label": "Revenues", "order": 100}, "income_loss_from_continuing_operations_before_tax": {"value": 525, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss": {"value": -2680593.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2680593.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}}}}, {"start_date": "2021-07-01", "end_date": "2021-09-30", "filing_date": "2021-11-12", "timeframe": "quarterly", "fiscal_period": "Q3", "fiscal_year": "2021", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001654954-21-012022", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001654954-21-012022/files/mnpr_10q_htm.xml", "financials": {"comprehensive_income": {"comprehensive_income_loss_attributable_to_parent": {"value": -2458434.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "other_comprehensive_income_loss": {"value": 9, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss": {"value": -2458434.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}}, "income_statement": {"participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "operating_expenses": {"value": 2459020.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "net_income_loss_attributable_to_parent": {"value": -2458443.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "other_operating_expenses": {"value": 631698, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "interest_income_expense_after_provision_for_losses": {"value": 577, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2458443.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "research_and_development": {"value": 1827322.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "operating_income_loss": {"value": -2459020.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "net_income_loss": {"value": -2458443.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 577, "unit": "USD", "label": "Revenues", "order": 100}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "income_loss_from_continuing_operations_after_tax": {"value": -2458443.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "costs_and_expenses": {"value": 2459597.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_before_tax": {"value": 577, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "interest_income_expense_operating_net": {"value": 577, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}}, "balance_sheet": {"assets": {"value": 22517222.0, "unit": "USD", "label": "Assets", "order": 100}, "equity": {"value": 21277285.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 1239937.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 21277285.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "liabilities_and_equity": {"value": 22517222.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": 1239937.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 22448364.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_assets": {"value": 68858, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "commitments_and_contingencies": {"value": 0, "unit": "USD", "label": "Commitments and Contingencies", "order": 900}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}}, "cash_flow_statement": {"net_cash_flow_from_financing_activities": {"value": -9978, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_continuing": {"value": -1951286.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities_continuing": {"value": -1941316.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 8, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities": {"value": -1941316.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities_continuing": {"value": 8, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_financing_activities_continuing": {"value": -9978, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": -1951286.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}}}}, {"start_date": "2021-04-01", "end_date": "2021-06-30", "filing_date": "2021-08-12", "timeframe": "quarterly", "fiscal_period": "Q2", "fiscal_year": "2021", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001654954-21-008791", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001654954-21-008791/files/mnpr_10q_htm.xml", "financials": {"cash_flow_statement": {"net_cash_flow_continuing": {"value": -1430263.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow": {"value": -1430263.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -1406120.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities": {"value": -24003, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": -140, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_from_operating_activities": {"value": -1406120.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_investing_activities": {"value": -140, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_financing_activities_continuing": {"value": -24003, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}}, "balance_sheet": {"liabilities": {"value": 1103640.0, "unit": "USD", "label": "Liabilities", "order": 600}, "current_assets": {"value": 24388414.0, "unit": "USD", "label": "Current Assets", "order": 200}, "equity_attributable_to_parent": {"value": 23353632.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 68858, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 23353632.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": -23353632.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "liabilities_and_equity": {"value": 24457272.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "assets": {"value": 24457272.0, "unit": "USD", "label": "Assets", "order": 100}}, "income_statement": {"operating_income_loss": {"value": -2092395.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "net_income_loss": {"value": -2080169.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "revenues": {"value": 12226, "unit": "USD", "label": "Revenues", "order": 100}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2080169.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "income_loss_from_continuing_operations_after_tax": {"value": -2080169.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_income_expense_after_provision_for_losses": {"value": 12226, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "costs_and_expenses": {"value": 2104621.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "interest_income_expense_operating_net": {"value": 12226, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "research_and_development": {"value": 1476430.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "operating_expenses": {"value": 2092395.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "other_operating_expenses": {"value": 615965, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "income_loss_from_continuing_operations_before_tax": {"value": -2080169.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "net_income_loss_attributable_to_parent": {"value": -2080169.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}}, "comprehensive_income": {"comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "comprehensive_income_loss_attributable_to_parent": {"value": -2080224.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss": {"value": -2080224.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": -57, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}}}, {"start_date": "2021-01-01", "end_date": "2021-03-31", "filing_date": "2021-05-13", "timeframe": "quarterly", "fiscal_period": "Q1", "fiscal_year": "2021", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "source_filing_url": "https://api.polygon.io/v1/reference/sec/filings/0001654954-21-005623", "source_filing_file_url": "http://api.polygon.io/v1/reference/sec/filings/0001654954-21-005623/files/mono-20210331.xml", "financials": {"balance_sheet": {"current_assets": {"value": 25837682.0, "unit": "USD", "label": "Current Assets", "order": 200}, "current_liabilities": {"value": 806272, "unit": "USD", "label": "Current Liabilities", "order": 700}, "equity_attributable_to_parent": {"value": 25100268.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "equity": {"value": 25100268.0, "unit": "USD", "label": "Equity", "order": 1400}, "equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 68858, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "liabilities_and_equity": {"value": 25906540.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "liabilities": {"value": -25100268.0, "unit": "USD", "label": "Liabilities", "order": 600}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "assets": {"value": 25906540.0, "unit": "USD", "label": "Assets", "order": 100}}, "income_statement": {"preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "interest_income_expense_operating_net": {"value": 10696, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "net_income_loss_available_to_common_stockholders_basic": {"value": -1884019.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss": {"value": -1884019.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "net_income_loss_attributable_to_parent": {"value": -1884019.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 1206779.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": -1884019.0, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "revenues": {"value": 10696, "unit": "USD", "label": "Revenues", "order": 100}, "operating_expenses": {"value": 1894715.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "operating_income_loss": {"value": -1894715.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "interest_income_expense_after_provision_for_losses": {"value": 10696, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "costs_and_expenses": {"value": 1905411.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "income_loss_from_continuing_operations_after_tax": {"value": -1884019.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}, "other_operating_expenses": {"value": 687936, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -1881245.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "comprehensive_income_loss_attributable_to_parent": {"value": -1881245.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}, "other_comprehensive_income_loss": {"value": 2774, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities": {"value": 2774, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}, "net_cash_flow_from_operating_activities_continuing": {"value": -1938060.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_financing_activities_continuing": {"value": 10921290.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow": {"value": 8986004.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_financing_activities": {"value": 10921290.0, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow_from_investing_activities_continuing": {"value": 2774, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": 8986004.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -1938060.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}}}}, {"start_date": "2020-10-01", "end_date": "2020-12-31", "timeframe": "quarterly", "fiscal_period": "Q4", "fiscal_year": "2020", "cik": "0001645469", "sic": "2834", "tickers": ["MNPR"], "company_name": "Monopar Therapeutics", "financials": {"balance_sheet": {"equity_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Equity Attributable To Noncontrolling Interest", "order": 1500}, "noncurrent_assets": {"value": 68858, "unit": "USD", "label": "Noncurrent Assets", "order": 300}, "equity": {"value": 15691991.0, "unit": "USD", "label": "Equity", "order": 1400}, "current_liabilities": {"value": 1176666.0, "unit": "USD", "label": "Current Liabilities", "order": 700}, "assets": {"value": 16868657.0, "unit": "USD", "label": "Assets", "order": 100}, "liabilities_and_equity": {"value": 16868657.0, "unit": "USD", "label": "Liabilities And Equity", "order": 1900}, "equity_attributable_to_parent": {"value": 15691991.0, "unit": "USD", "label": "Equity Attributable To Parent", "order": 1600}, "current_assets": {"value": 16799799.0, "unit": "USD", "label": "Current Assets", "order": 200}, "noncurrent_liabilities": {"value": 0, "unit": "USD", "label": "Noncurrent Liabilities", "order": 800}, "liabilities": {"value": 1176666.0, "unit": "USD", "label": "Liabilities", "order": 600}}, "income_statement": {"net_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Net Income/Loss Attributable To Noncontrolling Interest", "order": 3300}, "income_loss_from_continuing_operations_after_tax": {"value": -2128448.0, "unit": "USD", "label": "Income/Loss From Continuing Operations After Tax", "order": 1400}, "interest_income_expense_after_provision_for_losses": {"value": 9902, "unit": "USD", "label": "Interest Income/Expense After Provision For Losses", "order": 2800}, "costs_and_expenses": {"value": 2270652.0, "unit": "USD", "label": "Costs And Expenses", "order": 600}, "net_income_loss_available_to_common_stockholders_basic": {"value": -2128448.0, "unit": "USD", "label": "Net Income/Loss Available To Common Stockholders, Basic", "order": 3700}, "net_income_loss_attributable_to_parent": {"value": -2128448.0, "unit": "USD", "label": "Net Income/Loss Attributable To Parent", "order": 3500}, "research_and_development": {"value": 1632373.0, "unit": "USD", "label": "Research and Development", "order": 1030}, "income_loss_from_continuing_operations_before_tax": {"value": 9902, "unit": "USD", "label": "Income/Loss From Continuing Operations Before Tax", "order": 1500}, "operating_expenses": {"value": 2260750.0, "unit": "USD", "label": "Operating Expenses", "order": 1000}, "revenues": {"value": 9902, "unit": "USD", "label": "Revenues", "order": 100}, "provision_for_loan_lease_and_other_losses": {"value": 0, "unit": "USD", "label": "Provision For Loan, Lease, And Other Losses", "order": 4000}, "preferred_stock_dividends_and_other_adjustments": {"value": 0, "unit": "USD", "label": "Preferred Stock Dividends And Other Adjustments", "order": 3900}, "net_income_loss": {"value": -2128448.0, "unit": "USD", "label": "Net Income/Loss", "order": 3200}, "other_operating_expenses": {"value": 628377, "unit": "USD", "label": "Other Operating Expenses", "order": 1040}, "participating_securities_distributed_and_undistributed_earnings_loss_basic": {"value": 0, "unit": "USD", "label": "Participating Securities, Distributed And Undistributed Earnings/Loss, Basic", "order": 3800}, "interest_income_expense_operating_net": {"value": 9902, "unit": "USD", "label": "Interest Income/Expense Operating, Net", "order": 2900}, "operating_income_loss": {"value": -2260750.0, "unit": "USD", "label": "Operating Income/Loss", "order": 1100}, "benefits_costs_expenses": {"value": 0, "unit": "USD", "label": "Benefits Costs and Expenses", "order": 200}}, "comprehensive_income": {"comprehensive_income_loss": {"value": -2126277.0, "unit": "USD", "label": "Comprehensive Income/Loss", "order": 100}, "other_comprehensive_income_loss": {"value": 4178296.0, "unit": "USD", "label": "Other Comprehensive Income/Loss", "order": 400}, "comprehensive_income_loss_attributable_to_parent": {"value": -2126277.0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Parent", "order": 300}, "comprehensive_income_loss_attributable_to_noncontrolling_interest": {"value": 0, "unit": "USD", "label": "Comprehensive Income/Loss Attributable To Noncontrolling Interest", "order": 200}}, "cash_flow_statement": {"net_cash_flow_from_investing_activities_continuing": {"value": 2273, "unit": "USD", "label": "Net Cash Flow From Investing Activities, Continuing", "order": 500}, "net_cash_flow_continuing": {"value": -1248897.0, "unit": "USD", "label": "Net Cash Flow, Continuing", "order": 1200}, "net_cash_flow_from_operating_activities": {"value": -1240696.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities", "order": 100}, "net_cash_flow_from_financing_activities_continuing": {"value": -7140, "unit": "USD", "label": "Net Cash Flow From Financing Activities, Continuing", "order": 800}, "net_cash_flow_from_financing_activities": {"value": -7140, "unit": "USD", "label": "Net Cash Flow From Financing Activities", "order": 700}, "net_cash_flow": {"value": -1245563.0, "unit": "USD", "label": "Net Cash Flow", "order": 1100}, "net_cash_flow_from_operating_activities_continuing": {"value": -1240696.0, "unit": "USD", "label": "Net Cash Flow From Operating Activities, Continuing", "order": 200}, "net_cash_flow_from_investing_activities": {"value": 2273, "unit": "USD", "label": "Net Cash Flow From Investing Activities", "order": 400}}}}]